Mannosylated dextran nanoparticles: A pH-sensitive system engineered for immunomodulation through mannose targeting

Bioconjugate Chemistry

Volumn 22, Issue 5, 2011, Pages 949-957

  Cui, Lina ^a   Cohen, Joel A ^a   Broaders, Kyle E ^a   Beaudette, Tristan T ^a   Fréchet, Jean M J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOCOMPATIBILITY; PH SENSORS;

ANTIGEN PRESENTATION; BIOTHERAPEUTICS; CELL SURFACE RECEPTORS; DENDRITICS; IMMUNO MODULATIONS; PARTICULATE SYSTEMS; PH SENSITIVE; SENSITIVE MATERIALS; SENSITIVE SYSTEMS; TRIGGERED RELEASE;

LIGANDS;

DEXTRAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNOSE; NANOPARTICLE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; IMMUNOMODULATION; INTERNALIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PH;

EID: 80052994922     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100596w     Document Type: Article

References (59)

1. Pulendran, B. (2004) Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199, 227-250. (Pubitemid 38736775)
2. Jager, E., Jager, D., and Knuth, A. (1999) CTL-defined cancer vaccines: Perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Metastasis Rev. 18, 143-150. (Pubitemid 29411098)
3. Zinkernagel, R. M. (2002) Immunity, immunopathology and vaccines against HIV? Vaccine 20, 1913-1917. (Pubitemid 34450786)
4. Durrant, L. G., and Ramage, J. M. (2005) Development of cancer vaccines to activate cytotoxic T lymphocytes. Expert Opin. Biol. Ther. 5, 555-563. (Pubitemid 40593338)
5. Steinman, R. M., and Banchereau, J. (2007) Taking dendritic cells into medicine. Nature 449, 419-426. (Pubitemid 47509552)
6. Pulendran, B. (2004) Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199, 227-250. (Pubitemid 38736775)
7. Proudfoot, O., Apostolopoulos, V., and Pietersz, G. A. (2007) Receptor-mediated delivery of antigens to dendritic cells: Anticancer applications. Mol. Pharmaceutics 4, 58-72.
8. van Vliet, S. J., Garcia-Vallejo, J. J., and van Kooyk, Y. (2008) Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses. Immunol. Cell Biol. 86, 580-587.
9. Kanzler, H., Barrat, F. J., Hessel, E. M., and Coffman, R. L. (2007) Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13, 552-559. (Pubitemid 46830615)
10. Wilson-Welder, J. H., Torres, M. P., Kipper, M. J., Mallapragada, S. K., Wannemuehler, M. J., and Narasimhan, B. (2009) Vaccine adjuvants: current challenges and future approaches. J. Pharm. Sci. 98, 1278-1316.
11. Reddy, S. T., Swartz, M. A., and Hubbell, J. A. (2006) Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27, 573-579. (Pubitemid 44708833)
12. Singh, M., Chakrapani, A., and O'Hagon, D. (2007) Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev. Vaccines 6, 797-808. (Pubitemid 47607854)
13. Fahmy, T. M., Demento, S. L., Caplan, M. J., Mellman, I., and Saltzman, W. M. (2008) Design opportunities for actively targeted nanoparticle vaccines. Nanomedicine 3, 343-355. (Pubitemid 351827311)
14. Hubbell, J. A., Thomas, S. N., and Swartz, M. A. (2009) Materials engineering for immunomodulation. Nature 462, 449-460.
15. Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Paramonov, S. E., Dashe, J., and Frechet, J. M. J. (2008) Acid-degradable polyurethane particles for protein-based vaccines: Biological evaluation and in vitro analysis of particle degradation products. Mol. Pharmaceutics 5, 876-884.
16. Broaders, K. E., Cohen, J. A., Beaudette, T. T., Bachelder, E. M., and Frechet, J. M. J. (2009) Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. Proc. Natl. Acad. Sci. U.S.A.106, 5497-5502.
17. Kwon, Y. J., Standley, S. M., Goh, S. L., and Frechet, J. M. J. (2005) Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J. Controlled Release 105, 199-212. (Pubitemid 40941986)
18. Standley, S. M., Kwon, Y. J., Murthy, N., Kunisawa, J., Shastri, N., Guillaudeu, S. J., Lau, L., and Frechet, J. M. J. (2004) Acid-degradable particles for protein-based vaccines: Enhanced survival rate for tumorchallenged mice using ovalbumin model. Bioconjugate Chem. 15, 1281-1288. (Pubitemid 39552017)
19. Rock, K. L., and Shen, L. (2005) Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207, 166-183. (Pubitemid 41415016)
20. Beaudette, T. T., Bachelder, E. M., Cohen, J. A., Obermeyer, A. C., Broaders, K. E., Fréchet, J. M. J., Kang, E.-S., Mende, I., Tseng, W. W., Davidson, M. G., and Engleman, E. G. (2009) In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in aciddegradable microparticle vaccines. Mol. Pharmaceutics 6, 1160-1169.
21. Murthy, N., Xu, M. C., Schuck, S., Kunisawa, J., Shastri, N., and Frechet, J. M. J. (2003) A macromolecular delivery vehicle for proteinbased vaccines: Acid-degradable protein-loaded microgels. Proc. Natl. Acad. Sci. U.S.A.100, 4995-5000. (Pubitemid 36542647)
22. Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Dashe, J., and Frechet, J. M. J. (2008) Acetal-derivatized dextran: An acidresponsive biodegradable material for therapeutic applications. J. Am. Chem. Soc. 130, 10494-10495.
23. Cohen, J. A., Beaudette, T. T., Cohen, J. L., Broaders, K. E., Bachelder, E. M., and Fréchet, J. M. J. (2010) Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells. Adv. Mater.
24. Lorenzen, A., and Kennedy, S. W. (1993) A fluorescence-based protein assay for use with a microplate reader. Anal. Biochem. 214, 346-348. (Pubitemid 23300401)
25. Saxon, E., and Bertozzi, C. R. (2000) Cell surface engineering by a modified Staudinger reaction. Science 287, 2007-2010. (Pubitemid 30158675)
26. Becer, C. R., Hoogenboom, R., and Schubert, U. S. (2009) Click chemistry beyond metal-catalyzed cycloaddition. Angew. Chem., Int. Ed. 48, 4900-4908.
27. vanDijkWolthuis, W. N. E., Tsang, S. K. Y., Kettenesvanden-Bosch, J. J., and Hennink, W. E. (1997) A new class of polymerizable dextrans with hydrolyzable groups: hydroxyethyl methacrylated dextran with and without oligolactate spacer. Polymer 38, 6235-6242. (Pubitemid 127405748)
28. Kolb, H. C., Finn, M. G., and Sharpless, K. B. (2001) Click chemistry: Diverse chemical function from a few good reactions. Angew. Chem., Int. Ed. 40, 2004-2021.
29. Rodionov, V. O., Presolski, S. I., Gardinier, S., Lim, Y. H., and Finn, M. G. (2007) Benzimidazole and related Ligands for Cu-catalyzed azide-alkyne cycloaddition. J. Am. Chem. Soc. 129, 12696-12704. (Pubitemid 350004481)
30. Barre, A., Bourne, Y., Van Damme, E. J. M., Peumans, W. J., and Rouge, P. (2001) Mannose-binding plant lectins: Different structural scaffolds for a common sugar-recognition process. Biochimie 83, 645-651. (Pubitemid 32821228)
31. Ismaili, J., Rennesson, J., Aksoy, E., Vekemans, J., Vincart, B., Amraoui, Z., Van Laethem, F., Goldman, M., and Dubois, P. M. (2002) Monophosphoryl lipid A activates both human dendritic cells and T cells. J. Immunol. 168, 926-932. (Pubitemid 34049597)
32. Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P. A., and Kurts, C. (2007) Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316, 612-616. (Pubitemid 46683149)
33. Taylor, P. R., Gordon, S., and Martinez-Pomares, L. (2005) The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 26, 104-110.
34. Taylor,M. E., Bezouska, K., and Drickamer, K. (1992) Contribution to ligand-binding by multiple carbohydrate-recognition domains in the macrophage mannsoe receptor. J. Biol. Chem. 267, 1719-1726.
35. van Kooyk, Y. (2008) C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem. Soc. Trans. 36, 1478-1481.
36. Largent, B. L., Walton, K. M., Hoppe, C. A., Lee, Y. C., and Schnaar, R. L. (1984) Carbohydrate-specific adhesion of alveolar macrophages to mannose-derivatized surfaces. J. Biol. Chem. 259, 1764-1769. (Pubitemid 14146564)
37. East, L., Rushton, S., Taylor, M. E., and Isacke, C. M. (2002) Characterization of sugar binding by the mannose receptor family member, Endo180. J. Biol. Chem. 277, 50469-50475. (Pubitemid 36042201)
38. McGreal, E. P., Rosas, M., Brown, G. D., Zamze, S., Wong, S. Y. C., Gordon, S., Martinez-Pomares, L., and Taylor, P. R. (2006) The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 16, 422-430.
39. McGreal, E. P., Miller, J. L., and Gordon, S. (2005) Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr. Opin. Immunol. 17, 18-24. (Pubitemid 40094008)
40. Mitchell, D. A., Fadden, A. J., and Drickamer, K. (2001) A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR - Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276, 28939-28945.
41. Mammen, M., Choi, S. K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem., Int. Ed. 37, 2755-2794.
42. White, K., Rades, T., Kearns, P., Toth, I., and Hook, S. (2006) Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm. Res. 23, 1473-1481. (Pubitemid 43993810)
43. Hattori, Y., Kawakami, S., Lu, Y., Nakamura, K., Yamashita, F., and Hashida, M. (2006) Enhanced DNA vaccine potency by mannosytated lipoplex after intraperitoneal administration. J. Gene Med. 8, 824-834. (Pubitemid 44097138)
44. Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., Tyler, P. C., and Davies, N. M. (2003) Liposomal delivery of antigen to human dendritic cells. Vaccine 21, 883-890. (Pubitemid 36126422)
45. Arigita, C., Bevaart, L., Everse, L. A., Koning, G. A., Hennink, W. E., Crommelin, D. J. A., van de Winkel, J. G. J., van Vugt, M. J., Kersten, G. F. A., and Jiskoot, W. (2003) Liposomal meningococcal B vaccination: Role of dendritic cell targeting in the development of a protective immune response. Infect. Immun. 71, 5210-5218. (Pubitemid 37070766)
46. Kim, T. H., Jin, H., Kim, H. W., Cho, M. H., and Cho, C. S. (2006) Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol. Cancer Therapeut. 5, 1723-1732. (Pubitemid 44323240)
47. Park, I. Y., Kim, I. Y., Yoo, M. K., Choi, Y. J., Cho, M. H., and Cho, C. S. (2008) Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int. J. Pharm. 359, 280-287.
48. Wattendorf, U., Coullerez, G., Voros, J., Textor, M., and Merkle, H. P. (2008) Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigenpresenting cells. Langmuir 24, 11790-11802.
49. Rieger, J., Freichels, H., Imberty, A., Putaux, J. L., Delair, T., Jerome, C., and Auzely-Velty, R. (2009) Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. Biomacromolecules 10, 651-657.
50. Su, R. M., Li, L., Chen, X. P., Han, J. H., and Han, S. F. (2009) Multivalent mannose-displaying nanoparticles constructed from poly-{styrene-co-(maleic anhydride)-alt-styrene}. Org. Biomol. Chem. 7, 2040-2045.
51. Irache, J. M., Salman, H. H., Gamazo, C., and Espuelas, S. (2008) Mannose-targeted systems for the delivery of therapeutics. Expert Opin. Drug Delivery 5, 703-724. (Pubitemid 351998259)
52. Shen, Z. H., Reznikoff, G., Dranoff, G., and Rock, K. L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730. (Pubitemid 127470530)
53. Karttunen, J., Sanderson, S., and Shastri, N. (1992) Detection of rare antigen-presenting cells by the LacZ T-cells activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. U.S.A.89, 6020-6024.
54. Karttunen, J., and Shastri, N. (1991) Measurement of ligandinduced activation in single viable T-cells using the LacZ reporter gene. Proc. Natl. Acad. Sci. U.S.A.88, 3972-3976. (Pubitemid 21916746)
55. Bilati, U., Allemann, E., and Doelker, E. (2003) Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharmaceut. Dev. Technol. 8, 1-9. (Pubitemid 36337473)
56. Higashi, N., Fujioka, K., Denda-Nagai, K., Hashimoto, S., Nagai, S., Sato, T., Fujita, Y., Morikawa, A., Tsuiji, M., Miyata-Takeuchi, M., Sano, Y., Suzuki, N., Yamamoto, K., Matsushima, K., and Irimura, T. (2002) The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocytederived immature dendritic cells. J. Biol. Chem. 277, 20686-20693. (Pubitemid 34967372)
57. van Vliet, S. J., Saeland, E., and van Kooyk, Y. (2008) Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol. 29, 83-90.
58. Beaudette, T. T., Cohen, J. A., Bachelder, E. M., Broaders, K. E., Cohen, J. L., Engleman, E. G., and Fréchet, J. M. J. (2009) Chemoselective ligation in the functionalization of polysaccharide-based particles. J. Am. Chem. Soc. 131, 10360-10361.
59. Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Fréchet, J. M. J., Albrecht, M. T., Mateczun, A. J., Ainslie, K. M., Pesce, J. T., and Keane-Myers, A. M. (2010) In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol. Pharmaceutics 7, 826-835.